Nalaganje...
Efficacy and Safety of Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C in Persons With Sickle Cell Disease
Patients with sickle cell disease are at high risk for chronic hepatitis C infection. Prior treatment has been limited due to the use of ribavirin causing hemolytic anemia and interferon causing cytopenias. We demonstrate the safety and efficacy of fixed-dose combination ledipasvir and sofosbuvir fo...
Shranjeno v:
| izdano v: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6248462/ https://ncbi.nlm.nih.gov/pubmed/28505305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix441 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|